Current medicineuses technology whenever is possible to treat and prevent disease. Neurology, in particular, uses imaging techniques available in the study of diseases of the nervous system, including dementia. Using a Magnetic Resonance Imaging (MRI) can help a neurologist to properly diagnose a specific dementia. New imaging techniques such as PET-PIB have been developed intended only for the investigation of dementia.
At present, major studies and clinical trials include associated studiesof neuroimaging that aim to determine the effect of the treatment on the patient status. The long-term clinical studies associated with neuroimaging allow not only following the evolution of the disease through changes in the human brain, but also associate these changes with the clinical progression. In the future, the use of neuroimaging in combination with other techniques, is expected to be a tool to predict the subsequent development of dementia.
Neurons are cells of the nervous system. Unlike other cells, the neuron has a cell body (soma) and an extension (axon) that receives and sends stimuli to other cells. This communication is called neural plasticity, a property that can be trained through cognitive stimulation.
Comprehensive review of the cognitive , behavioral and emotional functions that can be altered as a result of functional impairment and / or structural central nervous system.
Non-pharmacological treatments are therapeutic interventions that do not dispense drugs to stimulate the person with dementia at a cognitive level . This treatment does not replace drugs,in any case it is complementary. One of the paradigmatic examples of non-pharmacological treatment is the Integral Psychostimulation Program (IPP).